(VIANEWS) – UP Fintech Holding Limited (TIGR), Repligen Corporation (RGEN), MEDIFAST (MED) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. UP Fintech Holding Limited (TIGR)

74.4% sales growth and 17.18% return on equity

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors.

UP Fintech Holding Limited’s sales growth this year is anticipated to be 127.6% and 49.6% for next year.

Year-on-year quarterly revenue growth grew by 245.7%, now sitting on 182.23M for the twelve trailing months.

Volume

Today’s last reported volume for UP Fintech Holding Limited is 1606530 which is 80.73% below its average volume of 8337330.

UP Fintech Holding Limited’s sales growth is a negative 0% for the ongoing quarter and 74.4% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.18%.

Volatility

UP Fintech Holding Limited’s last day, last week, and last month’s current intraday variation average was 2.08%, 2.61%, and 3.68%, respectively.

UP Fintech Holding Limited’s highest amplitude of average volatility was 6.33% (day), 9.13% (last week), and 9.06% (last month), respectively.

UP Fintech Holding Limited’s Stock Yearly Top and Bottom Value

UP Fintech Holding Limited’s stock is valued at $4.91 at 19:22 EST, way below its 52-week high of $38.50 and way above its 52-week low of $4.16.

UP Fintech Holding Limited’s Moving Average

UP Fintech Holding Limited’s worth is way below its 50-day moving average of $6.62 and way below its 200-day moving average of $15.15.

2. Repligen Corporation (RGEN)

51.5% sales growth and 8.37% return on equity

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally.

Repligen Corporation’s sales growth this year is expected to be 81.4% and 20.1% for next year.

Year-on-year quarterly revenue growth grew by 89.5%, now sitting on 592.66M for the twelve trailing months.

Volume

Today’s last reported volume for Repligen Corporation is 311996 which is 20.18% below its average volume of 390900.

Repligen Corporation’s sales growth for the next quarter is 51.5%. The company’s growth estimates for the current quarter and the next is 25% and 1.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.37%.

Volatility

Repligen Corporation’s last day, last week, and last month’s current intraday variation average was 1.90%, 1.68%, and 2.85%, respectively.

Repligen Corporation’s highest amplitude of average volatility was 4.00% (day), 4.17% (last week), and 5.38% (last month), respectively.

Repligen Corporation’s Stock Yearly Top and Bottom Value

Repligen Corporation’s stock is valued at $264.65 at 19:22 EST, way below its 52-week high of $327.32 and way above its 52-week low of $162.29.

Repligen Corporation’s Moving Average

Repligen Corporation’s worth is under its 50-day moving average of $270.87 and way above its 200-day moving average of $236.19.

3. MEDIFAST (MED)

46.2% sales growth and 93.98% return on equity

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific.

MEDIFAST’s sales growth this year is expected to be 63.5% and 18% for next year.

Year-on-year quarterly revenue growth grew by 52.3%, now sitting on 1.41B for the twelve trailing months.

Volume

Today’s last reported volume for MEDIFAST is 90504 which is 23.08% below its average volume of 117669.

MEDIFAST’s sales growth for the next quarter is 46.2%. The company’s growth estimates for the ongoing quarter and the next is 16.5% and 21.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 93.98%.

Volatility

MEDIFAST’s last day, last week, and last month’s current intraday variation average was 0.67%, 1.24%, and 2.02%, respectively.

MEDIFAST’s highest amplitude of average volatility was 4.07% (day), 3.04% (last week), and 3.84% (last month), respectively.

MEDIFAST’s Stock Yearly Top and Bottom Value

MEDIFAST’s stock is valued at $209.43 at 19:22 EST, way below its 52-week high of $336.99 and way above its 52-week low of $184.48.

MEDIFAST’s Moving Average

MEDIFAST’s value is below its 50-day moving average of $210.74 and way under its 200-day moving average of $240.18.

4. ChannelAdvisor Corporation (ECOM)

7.4% sales growth and 14.49% return on equity

ChannelAdvisor Corporation provides software-as-a-service (SaaS) solutions in the United States and internationally.

ChannelAdvisor Corporation’s sales growth this year is expected to be 14.8% and 9.4% for next year.

Year-on-year quarterly revenue growth grew by 17.8%, now sitting on 162.6M for the twelve trailing months.

Volume

Today’s last reported volume for ChannelAdvisor Corporation is 56636 which is 60.46% below its average volume of 143238.

ChannelAdvisor Corporation’s sales growth for the next quarter is 7.4%. The company’s growth estimates for the current quarter and the next is a negative 14.3% and negative -17.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.49%.

Volatility

ChannelAdvisor Corporation’s last day, last week, and last month’s current intraday variation average was 1.46%, 0.86%, and 1.95%, respectively.

ChannelAdvisor Corporation’s highest amplitude of average volatility was 2.97% (day), 2.20% (last week), and 3.68% (last month), respectively.

ChannelAdvisor Corporation’s Stock Yearly Top and Bottom Value

ChannelAdvisor Corporation’s stock is valued at $24.68 at 19:22 EST, way under its 52-week high of $29.42 and way higher than its 52-week low of $15.16.

ChannelAdvisor Corporation’s Moving Average

ChannelAdvisor Corporation’s value is under its 50-day moving average of $25.55 and higher than its 200-day moving average of $24.67.

LEAVE A REPLY

Please enter your comment!
Please enter your name here